11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome.

Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 5

Abstract

Obesity and associated metabolic syndrome is one of the greatest health threat to the modern society. Cortisol excess and the glucocorticoid receptor signaling pathway in the metabolically active tissues have been implicated in the development of diabetes and obesity. The key enzyme in the regeneration of intracellular cortisol is 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). 11β-HSD1 increases local cortisol production in metabolically active tissue types such as adipose and liver. Recent studies have shown that mice deficient in this enzyme are resistant to diet induced obesity and have increased insulin and leptin sensitivity. Clinical and preclinical studies indicate that 11β-HSD1 inhibitors are likely to exert major pharmacological actions in metabolically active tissues. These effects suggest that inhibition of 11β-HSD1 in vivo may be a novel therapeutic target for obesity, diabetes, and metabolic syndrome. The advancement of numerous structural classes of selective 11β-HSD1 inhibitors further indicates that more refined design and screening for isoform and tissue selectivity would yield potential therapeutics in this area.

Authors and Affiliations

Amit Joharapurkar, Nirav Dhanesha, Gaurang Shah, Rajendra Kharul, Mukul Jain

Keywords

Related Articles

Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells.

Human umbilical vein endothelial cells (HUVECs) were established as in vitro models for the modulation of endothelial function and cell viability by statins. Emphasis was placed on the biphasic effects of the drugs on ni...

Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not?

Macrolides are the most widely prescribed antibiotics. Clarithromycin is a well-known inhibitor of cytochrome P450 CYP3A4 and causes numerous drug interactions that are not found for azithromycin. CYP3A4 is involved in t...

Comparison of the influence of halothane and isoflurane on airway transepithelial potential difference.

Bidirectional transport of Na(+) and Cl(-) ions by the epithelium controls production and composition of airway surface liquid and airway transepithelial potential difference and in these ways supports mucociliary transp...

Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system.

The present review gives an overview on the serotonin (5-hydroxytryptamine; 5-HT) system, its receptors and their relationship to central nervous system physiology and disorders. Additionally, we also introduce the recen...

Neutrophil-infiltrated paw edema induced by mannose-binding Dioclea violacea lectin.

Background: The potential edematogenic effect and the pharmacological characterization of a glucose-mannose-binding lectin from Dioclea violacea (DvL) were investigated. Methods: Paw edema was induced with DvL in control...

Download PDF file
  • EP ID EP145963
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

Amit Joharapurkar, Nirav Dhanesha, Gaurang Shah, Rajendra Kharul, Mukul Jain (2012). 11β-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome.. Pharmacological Reports, 64(5), 1055-1065. https://europub.co.uk/articles/-A-145963